id	sid	tid	token	lemma	pos
cord-346917-5dgnj11a	1	1	key	key	NN
cord-346917-5dgnj11a	1	2	:	:	:
cord-346917-5dgnj11a	2	1	cord-346917	cord-346917	NNS
cord-346917-5dgnj11a	2	2	-	-	HYPH
cord-346917-5dgnj11a	2	3	5dgnj11a	5dgnj11a	CD
cord-346917-5dgnj11a	2	4	authors	author	NNS
cord-346917-5dgnj11a	2	5	:	:	:
cord-346917-5dgnj11a	2	6	Kuppalli	Kuppalli	NNP
cord-346917-5dgnj11a	2	7	,	,	,
cord-346917-5dgnj11a	2	8	Krutika	Krutika	NNP
cord-346917-5dgnj11a	2	9	;	;	:
cord-346917-5dgnj11a	2	10	Rasmussen	Rasmussen	NNP
cord-346917-5dgnj11a	2	11	,	,	,
cord-346917-5dgnj11a	2	12	Angela	Angela	NNP
cord-346917-5dgnj11a	2	13	L.	L.	NNP
cord-346917-5dgnj11a	2	14	title	title	NN
cord-346917-5dgnj11a	2	15	:	:	:
cord-346917-5dgnj11a	3	1	A	a	DT
cord-346917-5dgnj11a	3	2	glimpse	glimpse	NN
cord-346917-5dgnj11a	3	3	into	into	IN
cord-346917-5dgnj11a	3	4	the	the	DT
cord-346917-5dgnj11a	3	5	eye	eye	NN
cord-346917-5dgnj11a	3	6	of	of	IN
cord-346917-5dgnj11a	3	7	the	the	DT
cord-346917-5dgnj11a	3	8	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	3	9	cytokine	cytokine	NN
cord-346917-5dgnj11a	3	10	storm	storm	NN
cord-346917-5dgnj11a	3	11	date	date	NN
cord-346917-5dgnj11a	3	12	:	:	:
cord-346917-5dgnj11a	3	13	2020	2020	CD
cord-346917-5dgnj11a	3	14	-	-	HYPH
cord-346917-5dgnj11a	3	15	05	05	CD
cord-346917-5dgnj11a	3	16	-	-	HYPH
cord-346917-5dgnj11a	3	17	07	07	CD
cord-346917-5dgnj11a	3	18	journal	journal	NN
cord-346917-5dgnj11a	3	19	:	:	:
cord-346917-5dgnj11a	4	1	EBioMedicine	ebiomedicine	NN
cord-346917-5dgnj11a	4	2	DOI	DOI	NNP
cord-346917-5dgnj11a	4	3	:	:	:
cord-346917-5dgnj11a	4	4	10.1016	10.1016	CD
cord-346917-5dgnj11a	4	5	/	/	SYM
cord-346917-5dgnj11a	4	6	j.ebiom.2020.102789	j.ebiom.2020.102789	NNP
cord-346917-5dgnj11a	4	7	sha	sha	NNP
cord-346917-5dgnj11a	4	8	:	:	:
cord-346917-5dgnj11a	4	9	16886f5c52cc823bf1c2a6139075959aabd1134c	16886f5c52cc823bf1c2a6139075959aabd1134c	CD
cord-346917-5dgnj11a	4	10	doc_id	doc_id	CD
cord-346917-5dgnj11a	4	11	:	:	:
cord-346917-5dgnj11a	4	12	346917	346917	CD
cord-346917-5dgnj11a	4	13	cord_uid	cord_uid	NNS
cord-346917-5dgnj11a	4	14	:	:	:
cord-346917-5dgnj11a	5	1	5dgnj11a	5dgnj11a	LS
cord-346917-5dgnj11a	5	2	nan	nan	NNP
cord-346917-5dgnj11a	6	1	The	the	DT
cord-346917-5dgnj11a	6	2	pathogenesis	pathogenesis	NN
cord-346917-5dgnj11a	6	3	of	of	IN
cord-346917-5dgnj11a	6	4	pandemic	pandemic	NN
cord-346917-5dgnj11a	6	5	coronavirus	coronavirus	NN
cord-346917-5dgnj11a	6	6	disease-2019	disease-2019	NNP
cord-346917-5dgnj11a	6	7	(	(	-LRB-
cord-346917-5dgnj11a	6	8	COVID-19	COVID-19	NNP
cord-346917-5dgnj11a	6	9	)	)	-RRB-
cord-346917-5dgnj11a	6	10	caused	cause	VBN
cord-346917-5dgnj11a	6	11	by	by	IN
cord-346917-5dgnj11a	6	12	severe	severe	JJ
cord-346917-5dgnj11a	6	13	acute	acute	JJ
cord-346917-5dgnj11a	6	14	respiratory	respiratory	JJ
cord-346917-5dgnj11a	6	15	syndrome	syndrome	NN
cord-346917-5dgnj11a	6	16	coronavirus	coronavirus	NN
cord-346917-5dgnj11a	6	17	2	2	CD
cord-346917-5dgnj11a	7	1	(	(	-LRB-
cord-346917-5dgnj11a	7	2	SARS	SARS	NNP
cord-346917-5dgnj11a	7	3	-	-	HYPH
cord-346917-5dgnj11a	7	4	CoV-2	CoV-2	NNP
cord-346917-5dgnj11a	7	5	)	)	-RRB-
cord-346917-5dgnj11a	7	6	likely	likely	RB
cord-346917-5dgnj11a	7	7	depends	depend	VBZ
cord-346917-5dgnj11a	7	8	heavily	heavily	RB
cord-346917-5dgnj11a	7	9	on	on	IN
cord-346917-5dgnj11a	7	10	disruption	disruption	NN
cord-346917-5dgnj11a	7	11	of	of	IN
cord-346917-5dgnj11a	7	12	immune	immune	JJ
cord-346917-5dgnj11a	7	13	and	and	CC
cord-346917-5dgnj11a	7	14	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	7	15	processes	process	NNS
cord-346917-5dgnj11a	7	16	.	.	.
cord-346917-5dgnj11a	8	1	Thus	thus	RB
cord-346917-5dgnj11a	8	2	far	far	RB
cord-346917-5dgnj11a	8	3	,	,	,
cord-346917-5dgnj11a	8	4	the	the	DT
cord-346917-5dgnj11a	8	5	precise	precise	JJ
cord-346917-5dgnj11a	8	6	immune	immune	JJ
cord-346917-5dgnj11a	8	7	mechanisms	mechanism	NNS
cord-346917-5dgnj11a	8	8	have	have	VBP
cord-346917-5dgnj11a	8	9	not	not	RB
cord-346917-5dgnj11a	8	10	been	be	VBN
cord-346917-5dgnj11a	8	11	fully	fully	RB
cord-346917-5dgnj11a	8	12	elucidated	elucidate	VBN
cord-346917-5dgnj11a	8	13	or	or	CC
cord-346917-5dgnj11a	8	14	studied	study	VBN
cord-346917-5dgnj11a	8	15	in	in	IN
cord-346917-5dgnj11a	8	16	detail	detail	NN
cord-346917-5dgnj11a	8	17	.	.	.
cord-346917-5dgnj11a	9	1	In	in	IN
cord-346917-5dgnj11a	9	2	this	this	DT
cord-346917-5dgnj11a	9	3	issue	issue	NN
cord-346917-5dgnj11a	9	4	of	of	IN
cord-346917-5dgnj11a	9	5	EBioMedicine	EBioMedicine	NNP
cord-346917-5dgnj11a	9	6	,	,	,
cord-346917-5dgnj11a	9	7	Liu	Liu	NNP
cord-346917-5dgnj11a	9	8	and	and	CC
cord-346917-5dgnj11a	9	9	colleagues	colleague	NNS
cord-346917-5dgnj11a	9	10	[	[	-LRB-
cord-346917-5dgnj11a	9	11	1	1	CD
cord-346917-5dgnj11a	9	12	]	]	-RRB-
cord-346917-5dgnj11a	9	13	showed	show	VBD
cord-346917-5dgnj11a	9	14	that	that	IN
cord-346917-5dgnj11a	9	15	patients	patient	NNS
cord-346917-5dgnj11a	9	16	with	with	IN
cord-346917-5dgnj11a	9	17	severe	severe	JJ
cord-346917-5dgnj11a	9	18	COVID-19	COVID-19	NNP
cord-346917-5dgnj11a	9	19	had	have	VBD
cord-346917-5dgnj11a	9	20	lymphopenia	lymphopenia	VBN
cord-346917-5dgnj11a	9	21	and	and	CC
cord-346917-5dgnj11a	9	22	increased	increase	VBN
cord-346917-5dgnj11a	9	23	neutrophil	neutrophil	NN
cord-346917-5dgnj11a	9	24	counts	count	NNS
cord-346917-5dgnj11a	9	25	along	along	IN
cord-346917-5dgnj11a	9	26	with	with	IN
cord-346917-5dgnj11a	9	27	high	high	JJ
cord-346917-5dgnj11a	9	28	levels	level	NNS
cord-346917-5dgnj11a	9	29	of	of	IN
cord-346917-5dgnj11a	9	30	circulating	circulate	VBG
cord-346917-5dgnj11a	9	31	pro	pro	JJ
cord-346917-5dgnj11a	9	32	-	-	JJ
cord-346917-5dgnj11a	9	33	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	9	34	cytokines	cytokine	NNS
cord-346917-5dgnj11a	9	35	compared	compare	VBN
cord-346917-5dgnj11a	9	36	to	to	IN
cord-346917-5dgnj11a	9	37	patients	patient	NNS
cord-346917-5dgnj11a	9	38	with	with	IN
cord-346917-5dgnj11a	9	39	mild	mild	JJ
cord-346917-5dgnj11a	9	40	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	9	41	illness	illness	NN
cord-346917-5dgnj11a	9	42	.	.	.
cord-346917-5dgnj11a	10	1	The	the	DT
cord-346917-5dgnj11a	10	2	investigators	investigator	NNS
cord-346917-5dgnj11a	10	3	used	use	VBD
cord-346917-5dgnj11a	10	4	flow	flow	NN
cord-346917-5dgnj11a	10	5	cytometry	cytometry	NN
cord-346917-5dgnj11a	10	6	to	to	TO
cord-346917-5dgnj11a	10	7	investigate	investigate	VB
cord-346917-5dgnj11a	10	8	immune	immune	JJ
cord-346917-5dgnj11a	10	9	phenotype	phenotype	NN
cord-346917-5dgnj11a	10	10	and	and	CC
cord-346917-5dgnj11a	10	11	function	function	NN
cord-346917-5dgnj11a	10	12	of	of	IN
cord-346917-5dgnj11a	10	13	peripheral	peripheral	JJ
cord-346917-5dgnj11a	10	14	blood	blood	NN
cord-346917-5dgnj11a	10	15	mononuclear	mononuclear	NN
cord-346917-5dgnj11a	10	16	cells	cell	NNS
cord-346917-5dgnj11a	10	17	(	(	-LRB-
cord-346917-5dgnj11a	10	18	PBMC	PBMC	NNP
cord-346917-5dgnj11a	10	19	)	)	-RRB-
cord-346917-5dgnj11a	10	20	,	,	,
cord-346917-5dgnj11a	10	21	as	as	RB
cord-346917-5dgnj11a	10	22	well	well	RB
cord-346917-5dgnj11a	10	23	as	as	IN
cord-346917-5dgnj11a	10	24	quantified	quantify	VBN
cord-346917-5dgnj11a	10	25	plasma	plasma	NN
cord-346917-5dgnj11a	10	26	cytokine	cytokine	NN
cord-346917-5dgnj11a	10	27	levels	level	NNS
cord-346917-5dgnj11a	10	28	,	,	,
cord-346917-5dgnj11a	10	29	from	from	IN
cord-346917-5dgnj11a	10	30	40	40	CD
cord-346917-5dgnj11a	10	31	COVID-19	covid-19	CD
cord-346917-5dgnj11a	10	32	patients	patient	NNS
cord-346917-5dgnj11a	10	33	.	.	.
cord-346917-5dgnj11a	11	1	In	in	IN
cord-346917-5dgnj11a	11	2	particular	particular	JJ
cord-346917-5dgnj11a	11	3	,	,	,
cord-346917-5dgnj11a	11	4	substantial	substantial	JJ
cord-346917-5dgnj11a	11	5	depletion	depletion	NN
cord-346917-5dgnj11a	11	6	of	of	IN
cord-346917-5dgnj11a	11	7	CD8	CD8	NNP
cord-346917-5dgnj11a	11	8	+	+	CC
cord-346917-5dgnj11a	11	9	T	T	NNP
cord-346917-5dgnj11a	11	10	cells	cell	NNS
cord-346917-5dgnj11a	11	11	were	be	VBD
cord-346917-5dgnj11a	11	12	associated	associate	VBN
cord-346917-5dgnj11a	11	13	with	with	IN
cord-346917-5dgnj11a	11	14	disease	disease	NN
cord-346917-5dgnj11a	11	15	severity	severity	NN
cord-346917-5dgnj11a	11	16	,	,	,
cord-346917-5dgnj11a	11	17	and	and	CC
cord-346917-5dgnj11a	11	18	both	both	CC
cord-346917-5dgnj11a	11	19	the	the	DT
cord-346917-5dgnj11a	11	20	ratios	ratio	NNS
cord-346917-5dgnj11a	11	21	of	of	IN
cord-346917-5dgnj11a	11	22	neutrophils	neutrophil	NNS
cord-346917-5dgnj11a	11	23	to	to	IN
cord-346917-5dgnj11a	11	24	CD8	CD8	NNP
cord-346917-5dgnj11a	11	25	+	+	CC
cord-346917-5dgnj11a	11	26	T	T	NNP
cord-346917-5dgnj11a	11	27	cells	cell	NNS
cord-346917-5dgnj11a	11	28	(	(	-LRB-
cord-346917-5dgnj11a	11	29	N8R	n8r	CD
cord-346917-5dgnj11a	11	30	)	)	-RRB-
cord-346917-5dgnj11a	11	31	and	and	CC
cord-346917-5dgnj11a	11	32	neutrophils	neutrophil	NNS
cord-346917-5dgnj11a	11	33	to	to	IN
cord-346917-5dgnj11a	11	34	lymphocytes	lymphocyte	NNS
cord-346917-5dgnj11a	11	35	(	(	-LRB-
cord-346917-5dgnj11a	11	36	NLR	NLR	NNP
cord-346917-5dgnj11a	11	37	)	)	-RRB-
cord-346917-5dgnj11a	11	38	were	be	VBD
cord-346917-5dgnj11a	11	39	predictive	predictive	JJ
cord-346917-5dgnj11a	11	40	of	of	IN
cord-346917-5dgnj11a	11	41	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	11	42	outcome	outcome	NN
cord-346917-5dgnj11a	11	43	.	.	.
cord-346917-5dgnj11a	12	1	These	these	DT
cord-346917-5dgnj11a	12	2	data	datum	NNS
cord-346917-5dgnj11a	12	3	suggest	suggest	VBP
cord-346917-5dgnj11a	12	4	that	that	IN
cord-346917-5dgnj11a	12	5	depletion	depletion	NN
cord-346917-5dgnj11a	12	6	of	of	IN
cord-346917-5dgnj11a	12	7	lymphocytes	lymphocyte	NNS
cord-346917-5dgnj11a	12	8	,	,	,
cord-346917-5dgnj11a	12	9	particularly	particularly	RB
cord-346917-5dgnj11a	12	10	cytotoxic	cytotoxic	JJ
cord-346917-5dgnj11a	12	11	T	t	NN
cord-346917-5dgnj11a	12	12	lymphocytes	lymphocyte	NNS
cord-346917-5dgnj11a	12	13	that	that	WDT
cord-346917-5dgnj11a	12	14	function	function	VBP
cord-346917-5dgnj11a	12	15	by	by	IN
cord-346917-5dgnj11a	12	16	eliminating	eliminate	VBG
cord-346917-5dgnj11a	12	17	infected	infected	JJ
cord-346917-5dgnj11a	12	18	cells	cell	NNS
cord-346917-5dgnj11a	12	19	,	,	,
cord-346917-5dgnj11a	12	20	coupled	couple	VBN
cord-346917-5dgnj11a	12	21	with	with	IN
cord-346917-5dgnj11a	12	22	neutrophils	neutrophil	NNS
cord-346917-5dgnj11a	12	23	capable	capable	JJ
cord-346917-5dgnj11a	12	24	of	of	IN
cord-346917-5dgnj11a	12	25	mediating	mediate	VBG
cord-346917-5dgnj11a	12	26	a	a	DT
cord-346917-5dgnj11a	12	27	proinflammatory	proinflammatory	JJ
cord-346917-5dgnj11a	12	28	"	"	``
cord-346917-5dgnj11a	12	29	cytokine	cytokine	NN
cord-346917-5dgnj11a	12	30	storm	storm	NN
cord-346917-5dgnj11a	12	31	"	"	''
cord-346917-5dgnj11a	12	32	may	may	MD
cord-346917-5dgnj11a	12	33	be	be	VB
cord-346917-5dgnj11a	12	34	key	key	JJ
cord-346917-5dgnj11a	12	35	players	player	NNS
cord-346917-5dgnj11a	12	36	in	in	IN
cord-346917-5dgnj11a	12	37	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	12	38	pathogenesis	pathogenesis	NN
cord-346917-5dgnj11a	12	39	.	.	.
cord-346917-5dgnj11a	13	1	While	while	IN
cord-346917-5dgnj11a	13	2	"	"	``
cord-346917-5dgnj11a	13	3	cytokine	cytokine	NN
cord-346917-5dgnj11a	13	4	storms	storm	NNS
cord-346917-5dgnj11a	13	5	"	"	''
cord-346917-5dgnj11a	13	6	have	have	VBP
cord-346917-5dgnj11a	13	7	long	long	RB
cord-346917-5dgnj11a	13	8	been	be	VBN
cord-346917-5dgnj11a	13	9	associated	associate	VBN
cord-346917-5dgnj11a	13	10	with	with	IN
cord-346917-5dgnj11a	13	11	acute	acute	JJ
cord-346917-5dgnj11a	13	12	respiratory	respiratory	JJ
cord-346917-5dgnj11a	13	13	distress	distress	NN
cord-346917-5dgnj11a	13	14	syndrome	syndrome	NN
cord-346917-5dgnj11a	13	15	(	(	-LRB-
cord-346917-5dgnj11a	13	16	ARDS	ARDS	NNP
cord-346917-5dgnj11a	13	17	)	)	-RRB-
cord-346917-5dgnj11a	13	18	caused	cause	VBN
cord-346917-5dgnj11a	13	19	by	by	IN
cord-346917-5dgnj11a	13	20	SARS	SARS	NNP
cord-346917-5dgnj11a	13	21	coronavirus	coronavirus	NN
cord-346917-5dgnj11a	13	22	(	(	-LRB-
cord-346917-5dgnj11a	13	23	SARS	SARS	NNP
cord-346917-5dgnj11a	13	24	-	-	HYPH
cord-346917-5dgnj11a	13	25	CoV	CoV	NNP
cord-346917-5dgnj11a	13	26	)	)	-RRB-
cord-346917-5dgnj11a	13	27	and	and	CC
cord-346917-5dgnj11a	13	28	MERS	MERS	NNP
cord-346917-5dgnj11a	13	29	coronavirus	coronavirus	NN
cord-346917-5dgnj11a	13	30	(	(	-LRB-
cord-346917-5dgnj11a	13	31	MERS	MERS	NNP
cord-346917-5dgnj11a	13	32	-	-	HYPH
cord-346917-5dgnj11a	13	33	CoV	CoV	NNP
cord-346917-5dgnj11a	13	34	)	)	-RRB-
cord-346917-5dgnj11a	14	1	[	[	-LRB-
cord-346917-5dgnj11a	14	2	2	2	CD
cord-346917-5dgnj11a	14	3	]	]	-RRB-
cord-346917-5dgnj11a	14	4	,	,	,
cord-346917-5dgnj11a	14	5	pro	pro	JJ
cord-346917-5dgnj11a	14	6	-	-	JJ
cord-346917-5dgnj11a	14	7	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	14	8	cytokine	cytokine	NN
cord-346917-5dgnj11a	14	9	dynamics	dynamic	NNS
cord-346917-5dgnj11a	14	10	in	in	IN
cord-346917-5dgnj11a	14	11	the	the	DT
cord-346917-5dgnj11a	14	12	context	context	NN
cord-346917-5dgnj11a	14	13	of	of	IN
cord-346917-5dgnj11a	14	14	cellular	cellular	JJ
cord-346917-5dgnj11a	14	15	immune	immune	JJ
cord-346917-5dgnj11a	14	16	responses	response	NNS
cord-346917-5dgnj11a	14	17	in	in	IN
cord-346917-5dgnj11a	14	18	COVID-19	COVID-19	NNP
cord-346917-5dgnj11a	14	19	have	have	VBP
cord-346917-5dgnj11a	14	20	not	not	RB
cord-346917-5dgnj11a	14	21	been	be	VBN
cord-346917-5dgnj11a	14	22	well	well	RB
cord-346917-5dgnj11a	14	23	-	-	HYPH
cord-346917-5dgnj11a	14	24	characterized	characterize	VBN
cord-346917-5dgnj11a	14	25	.	.	.
cord-346917-5dgnj11a	15	1	This	this	DT
cord-346917-5dgnj11a	15	2	study	study	NN
cord-346917-5dgnj11a	15	3	clearly	clearly	RB
cord-346917-5dgnj11a	15	4	demonstrates	demonstrate	VBZ
cord-346917-5dgnj11a	15	5	that	that	IN
cord-346917-5dgnj11a	15	6	severe	severe	JJ
cord-346917-5dgnj11a	15	7	COVID-19	covid-19	NN
cord-346917-5dgnj11a	15	8	is	be	VBZ
cord-346917-5dgnj11a	15	9	associated	associate	VBN
cord-346917-5dgnj11a	15	10	with	with	IN
cord-346917-5dgnj11a	15	11	significant	significant	JJ
cord-346917-5dgnj11a	15	12	increases	increase	NNS
cord-346917-5dgnj11a	15	13	in	in	IN
cord-346917-5dgnj11a	15	14	pro	pro	JJ
cord-346917-5dgnj11a	15	15	-	-	JJ
cord-346917-5dgnj11a	15	16	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	15	17	cytokines	cytokine	NNS
cord-346917-5dgnj11a	15	18	such	such	JJ
cord-346917-5dgnj11a	15	19	as	as	IN
cord-346917-5dgnj11a	15	20	IL-6	IL-6	NNP
cord-346917-5dgnj11a	15	21	as	as	RB
cord-346917-5dgnj11a	15	22	well	well	RB
cord-346917-5dgnj11a	15	23	as	as	IN
cord-346917-5dgnj11a	15	24	significant	significant	JJ
cord-346917-5dgnj11a	15	25	reductions	reduction	NNS
cord-346917-5dgnj11a	15	26	in	in	IN
cord-346917-5dgnj11a	15	27	CD8	CD8	NNP
cord-346917-5dgnj11a	15	28	+	+	CC
cord-346917-5dgnj11a	15	29	T	T	NNP
cord-346917-5dgnj11a	15	30	cells	cell	NNS
cord-346917-5dgnj11a	15	31	.	.	.
cord-346917-5dgnj11a	16	1	Th1	th1	CD
cord-346917-5dgnj11a	16	2	antiviral	antiviral	JJ
cord-346917-5dgnj11a	16	3	responses	response	NNS
cord-346917-5dgnj11a	16	4	appear	appear	VBP
cord-346917-5dgnj11a	16	5	to	to	TO
cord-346917-5dgnj11a	16	6	be	be	VB
cord-346917-5dgnj11a	16	7	suppressed	suppress	VBN
cord-346917-5dgnj11a	16	8	,	,	,
cord-346917-5dgnj11a	16	9	which	which	WDT
cord-346917-5dgnj11a	16	10	is	be	VBZ
cord-346917-5dgnj11a	16	11	supported	support	VBN
cord-346917-5dgnj11a	16	12	by	by	IN
cord-346917-5dgnj11a	16	13	increases	increase	NNS
cord-346917-5dgnj11a	16	14	in	in	IN
cord-346917-5dgnj11a	16	15	the	the	DT
cord-346917-5dgnj11a	16	16	Th2	th2	CD
cord-346917-5dgnj11a	16	17	cytokine	cytokine	NN
cord-346917-5dgnj11a	16	18	IL-10	IL-10	NNP
cord-346917-5dgnj11a	16	19	.	.	.
cord-346917-5dgnj11a	17	1	A	a	DT
cord-346917-5dgnj11a	17	2	recent	recent	JJ
cord-346917-5dgnj11a	17	3	study	study	NN
cord-346917-5dgnj11a	17	4	in	in	IN
cord-346917-5dgnj11a	17	5	21	21	CD
cord-346917-5dgnj11a	17	6	patients	patient	NNS
cord-346917-5dgnj11a	17	7	also	also	RB
cord-346917-5dgnj11a	17	8	demonstrated	demonstrate	VBD
cord-346917-5dgnj11a	17	9	that	that	IN
cord-346917-5dgnj11a	17	10	COVID-19	COVID-19	NNP
cord-346917-5dgnj11a	17	11	induced	induce	VBN
cord-346917-5dgnj11a	17	12	increases	increase	NNS
cord-346917-5dgnj11a	17	13	in	in	IN
cord-346917-5dgnj11a	17	14	IL-6	IL-6	NNP
cord-346917-5dgnj11a	17	15	and	and	CC
cord-346917-5dgnj11a	17	16	IL-10	IL-10	NNP
cord-346917-5dgnj11a	17	17	with	with	IN
cord-346917-5dgnj11a	17	18	corresponding	corresponding	JJ
cord-346917-5dgnj11a	17	19	lymphopenia	lymphopenia	NNP
cord-346917-5dgnj11a	17	20	[	[	-LRB-
cord-346917-5dgnj11a	17	21	3	3	CD
cord-346917-5dgnj11a	17	22	]	]	-RRB-
cord-346917-5dgnj11a	17	23	.	.	.
cord-346917-5dgnj11a	18	1	These	these	DT
cord-346917-5dgnj11a	18	2	data	datum	NNS
cord-346917-5dgnj11a	18	3	indicate	indicate	VBP
cord-346917-5dgnj11a	18	4	that	that	IN
cord-346917-5dgnj11a	18	5	cytokine	cytokine	NN
cord-346917-5dgnj11a	18	6	storms	storm	NNS
cord-346917-5dgnj11a	18	7	may	may	MD
cord-346917-5dgnj11a	18	8	,	,	,
cord-346917-5dgnj11a	18	9	in	in	IN
cord-346917-5dgnj11a	18	10	concert	concert	NN
cord-346917-5dgnj11a	18	11	with	with	IN
cord-346917-5dgnj11a	18	12	suppressed	suppress	VBN
cord-346917-5dgnj11a	18	13	Th1	th1	NN
cord-346917-5dgnj11a	18	14	antiviral	antiviral	JJ
cord-346917-5dgnj11a	18	15	adaptive	adaptive	JJ
cord-346917-5dgnj11a	18	16	responses	response	NNS
cord-346917-5dgnj11a	18	17	,	,	,
cord-346917-5dgnj11a	18	18	underlie	underlie	VBP
cord-346917-5dgnj11a	18	19	the	the	DT
cord-346917-5dgnj11a	18	20	pathogenesis	pathogenesis	NN
cord-346917-5dgnj11a	18	21	of	of	IN
cord-346917-5dgnj11a	18	22	severe	severe	JJ
cord-346917-5dgnj11a	18	23	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	18	24	disease	disease	NN
cord-346917-5dgnj11a	18	25	.	.	.
cord-346917-5dgnj11a	19	1	These	these	DT
cord-346917-5dgnj11a	19	2	findings	finding	NNS
cord-346917-5dgnj11a	19	3	are	be	VBP
cord-346917-5dgnj11a	19	4	valuable	valuable	JJ
cord-346917-5dgnj11a	19	5	for	for	IN
cord-346917-5dgnj11a	19	6	clinicians	clinician	NNS
cord-346917-5dgnj11a	19	7	as	as	IN
cord-346917-5dgnj11a	19	8	it	-PRON-	PRP
cord-346917-5dgnj11a	19	9	further	further	RB
cord-346917-5dgnj11a	19	10	supports	support	VBZ
cord-346917-5dgnj11a	19	11	the	the	DT
cord-346917-5dgnj11a	19	12	significant	significant	JJ
cord-346917-5dgnj11a	19	13	effect	effect	NN
cord-346917-5dgnj11a	19	14	SARS	SARS	NNP
cord-346917-5dgnj11a	19	15	-	-	HYPH
cord-346917-5dgnj11a	19	16	CoV-2	CoV-2	NNP
cord-346917-5dgnj11a	19	17	has	have	VBZ
cord-346917-5dgnj11a	19	18	on	on	IN
cord-346917-5dgnj11a	19	19	the	the	DT
cord-346917-5dgnj11a	19	20	systemic	systemic	JJ
cord-346917-5dgnj11a	19	21	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	19	22	response	response	NN
cord-346917-5dgnj11a	19	23	and	and	CC
cord-346917-5dgnj11a	19	24	gives	give	VBZ
cord-346917-5dgnj11a	19	25	insight	insight	NN
cord-346917-5dgnj11a	19	26	on	on	IN
cord-346917-5dgnj11a	19	27	how	how	WRB
cord-346917-5dgnj11a	19	28	to	to	TO
cord-346917-5dgnj11a	19	29	identify	identify	VB
cord-346917-5dgnj11a	19	30	patients	patient	NNS
cord-346917-5dgnj11a	19	31	at	at	IN
cord-346917-5dgnj11a	19	32	risk	risk	NN
cord-346917-5dgnj11a	19	33	for	for	IN
cord-346917-5dgnj11a	19	34	severe	severe	JJ
cord-346917-5dgnj11a	19	35	disease	disease	NN
cord-346917-5dgnj11a	19	36	.	.	.
cord-346917-5dgnj11a	20	1	It	-PRON-	PRP
cord-346917-5dgnj11a	20	2	demonstrates	demonstrate	VBZ
cord-346917-5dgnj11a	20	3	potentially	potentially	RB
cord-346917-5dgnj11a	20	4	critical	critical	JJ
cord-346917-5dgnj11a	20	5	roles	role	NNS
cord-346917-5dgnj11a	20	6	for	for	IN
cord-346917-5dgnj11a	20	7	IL-2	IL-2	NNP
cord-346917-5dgnj11a	20	8	,	,	,
cord-346917-5dgnj11a	20	9	IL-6	IL-6	NNP
cord-346917-5dgnj11a	20	10	,	,	,
cord-346917-5dgnj11a	20	11	IL-10	IL-10	NNP
cord-346917-5dgnj11a	20	12	,	,	,
cord-346917-5dgnj11a	20	13	and	and	CC
cord-346917-5dgnj11a	20	14	IFN	IFN	NNP
cord-346917-5dgnj11a	20	15	-	-	HYPH
cord-346917-5dgnj11a	20	16	g	g	NNP
cord-346917-5dgnj11a	20	17	in	in	IN
cord-346917-5dgnj11a	20	18	severe	severe	JJ
cord-346917-5dgnj11a	20	19	disease	disease	NN
cord-346917-5dgnj11a	20	20	,	,	,
cord-346917-5dgnj11a	20	21	suggesting	suggest	VBG
cord-346917-5dgnj11a	20	22	that	that	IN
cord-346917-5dgnj11a	20	23	the	the	DT
cord-346917-5dgnj11a	20	24	magnitude	magnitude	NN
cord-346917-5dgnj11a	20	25	of	of	IN
cord-346917-5dgnj11a	20	26	the	the	DT
cord-346917-5dgnj11a	20	27	cytokine	cytokine	NN
cord-346917-5dgnj11a	20	28	storm	storm	NN
cord-346917-5dgnj11a	20	29	is	be	VBZ
cord-346917-5dgnj11a	20	30	associated	associate	VBN
cord-346917-5dgnj11a	20	31	with	with	IN
cord-346917-5dgnj11a	20	32	severity	severity	NN
cord-346917-5dgnj11a	20	33	of	of	IN
cord-346917-5dgnj11a	20	34	disease	disease	NN
cord-346917-5dgnj11a	20	35	.	.	.
cord-346917-5dgnj11a	21	1	Mean	Mean	NNP
cord-346917-5dgnj11a	21	2	IL-6	IL-6	NNP
cord-346917-5dgnj11a	21	3	concentrations	concentration	NNS
cord-346917-5dgnj11a	21	4	have	have	VBP
cord-346917-5dgnj11a	21	5	been	be	VBN
cord-346917-5dgnj11a	21	6	shown	show	VBN
cord-346917-5dgnj11a	21	7	to	to	TO
cord-346917-5dgnj11a	21	8	be	be	VB
cord-346917-5dgnj11a	21	9	2.9	2.9	CD
cord-346917-5dgnj11a	21	10	times	time	NNS
cord-346917-5dgnj11a	21	11	higher	high	JJR
cord-346917-5dgnj11a	21	12	in	in	IN
cord-346917-5dgnj11a	21	13	patients	patient	NNS
cord-346917-5dgnj11a	21	14	with	with	IN
cord-346917-5dgnj11a	21	15	severe	severe	JJ
cord-346917-5dgnj11a	21	16	disease	disease	NN
cord-346917-5dgnj11a	21	17	and	and	CC
cord-346917-5dgnj11a	21	18	maximal	maximal	JJ
cord-346917-5dgnj11a	21	19	IL-6	IL-6	NNP
cord-346917-5dgnj11a	21	20	highly	highly	RB
cord-346917-5dgnj11a	21	21	predictive	predictive	JJ
cord-346917-5dgnj11a	21	22	of	of	IN
cord-346917-5dgnj11a	21	23	respiratory	respiratory	JJ
cord-346917-5dgnj11a	21	24	failure	failure	NN
cord-346917-5dgnj11a	21	25	[	[	-LRB-
cord-346917-5dgnj11a	21	26	4	4	CD
cord-346917-5dgnj11a	21	27	,	,	,
cord-346917-5dgnj11a	21	28	5	5	CD
cord-346917-5dgnj11a	21	29	]	]	-RRB-
cord-346917-5dgnj11a	21	30	.	.	.
cord-346917-5dgnj11a	22	1	These	these	DT
cord-346917-5dgnj11a	22	2	data	datum	NNS
cord-346917-5dgnj11a	22	3	also	also	RB
cord-346917-5dgnj11a	22	4	suggest	suggest	VBP
cord-346917-5dgnj11a	22	5	that	that	IN
cord-346917-5dgnj11a	22	6	monitoring	monitor	VBG
cord-346917-5dgnj11a	22	7	N8R	n8r	CD
cord-346917-5dgnj11a	22	8	and	and	CC
cord-346917-5dgnj11a	22	9	NLR	NLR	NNP
cord-346917-5dgnj11a	22	10	over	over	IN
cord-346917-5dgnj11a	22	11	time	time	NN
cord-346917-5dgnj11a	22	12	could	could	MD
cord-346917-5dgnj11a	22	13	be	be	VB
cord-346917-5dgnj11a	22	14	a	a	DT
cord-346917-5dgnj11a	22	15	way	way	NN
cord-346917-5dgnj11a	22	16	to	to	TO
cord-346917-5dgnj11a	22	17	identify	identify	VB
cord-346917-5dgnj11a	22	18	patients	patient	NNS
cord-346917-5dgnj11a	22	19	early	early	RB
cord-346917-5dgnj11a	22	20	on	on	IN
cord-346917-5dgnj11a	22	21	at	at	IN
cord-346917-5dgnj11a	22	22	risk	risk	NN
cord-346917-5dgnj11a	22	23	for	for	IN
cord-346917-5dgnj11a	22	24	developing	develop	VBG
cord-346917-5dgnj11a	22	25	severe	severe	JJ
cord-346917-5dgnj11a	22	26	disease	disease	NN
cord-346917-5dgnj11a	22	27	[	[	-LRB-
cord-346917-5dgnj11a	22	28	6	6	CD
cord-346917-5dgnj11a	22	29	]	]	-RRB-
cord-346917-5dgnj11a	22	30	.	.	.
cord-346917-5dgnj11a	23	1	Understanding	understand	VBG
cord-346917-5dgnj11a	23	2	how	how	WRB
cord-346917-5dgnj11a	23	3	to	to	TO
cord-346917-5dgnj11a	23	4	identify	identify	VB
cord-346917-5dgnj11a	23	5	which	which	WDT
cord-346917-5dgnj11a	23	6	patients	patient	NNS
cord-346917-5dgnj11a	23	7	who	who	WP
cord-346917-5dgnj11a	23	8	present	present	VBP
cord-346917-5dgnj11a	23	9	with	with	IN
cord-346917-5dgnj11a	23	10	COVID-19	COVID-19	NNP
cord-346917-5dgnj11a	23	11	will	will	MD
cord-346917-5dgnj11a	23	12	go	go	VB
cord-346917-5dgnj11a	23	13	on	on	RP
cord-346917-5dgnj11a	23	14	to	to	TO
cord-346917-5dgnj11a	23	15	develop	develop	VB
cord-346917-5dgnj11a	23	16	severe	severe	JJ
cord-346917-5dgnj11a	23	17	disease	disease	NN
cord-346917-5dgnj11a	23	18	is	be	VBZ
cord-346917-5dgnj11a	23	19	of	of	IN
cord-346917-5dgnj11a	23	20	paramount	paramount	JJ
cord-346917-5dgnj11a	23	21	importance	importance	NN
cord-346917-5dgnj11a	23	22	to	to	IN
cord-346917-5dgnj11a	23	23	clinicians	clinician	NNS
cord-346917-5dgnj11a	23	24	.	.	.
cord-346917-5dgnj11a	24	1	Monitoring	monitor	VBG
cord-346917-5dgnj11a	24	2	N8R	n8r	CD
cord-346917-5dgnj11a	24	3	and	and	CC
cord-346917-5dgnj11a	24	4	NLR	NLR	NNP
cord-346917-5dgnj11a	24	5	over	over	IN
cord-346917-5dgnj11a	24	6	time	time	NN
cord-346917-5dgnj11a	24	7	may	may	MD
cord-346917-5dgnj11a	24	8	assist	assist	VB
cord-346917-5dgnj11a	24	9	frontline	frontline	JJ
cord-346917-5dgnj11a	24	10	clinicians	clinician	NNS
cord-346917-5dgnj11a	24	11	in	in	IN
cord-346917-5dgnj11a	24	12	identifying	identify	VBG
cord-346917-5dgnj11a	24	13	those	those	DT
cord-346917-5dgnj11a	24	14	at	at	IN
cord-346917-5dgnj11a	24	15	greatest	great	JJS
cord-346917-5dgnj11a	24	16	risk	risk	NN
cord-346917-5dgnj11a	24	17	for	for	IN
cord-346917-5dgnj11a	24	18	developing	develop	VBG
cord-346917-5dgnj11a	24	19	severe	severe	JJ
cord-346917-5dgnj11a	24	20	COVID-19	covid-19	NN
cord-346917-5dgnj11a	24	21	and	and	CC
cord-346917-5dgnj11a	24	22	prompt	prompt	VB
cord-346917-5dgnj11a	24	23	them	-PRON-	PRP
cord-346917-5dgnj11a	24	24	to	to	TO
cord-346917-5dgnj11a	24	25	institute	institute	VB
cord-346917-5dgnj11a	24	26	supportive	supportive	JJ
cord-346917-5dgnj11a	24	27	care	care	NN
cord-346917-5dgnj11a	24	28	earlier	early	RBR
cord-346917-5dgnj11a	24	29	or	or	CC
cord-346917-5dgnj11a	24	30	initiate	initiate	VB
cord-346917-5dgnj11a	24	31	transfer	transfer	NN
cord-346917-5dgnj11a	24	32	to	to	IN
cord-346917-5dgnj11a	24	33	a	a	DT
cord-346917-5dgnj11a	24	34	higher	high	JJR
cord-346917-5dgnj11a	24	35	level	level	NN
cord-346917-5dgnj11a	24	36	of	of	IN
cord-346917-5dgnj11a	24	37	care	care	NN
cord-346917-5dgnj11a	24	38	[	[	-LRB-
cord-346917-5dgnj11a	24	39	6	6	CD
cord-346917-5dgnj11a	24	40	]	]	-RRB-
cord-346917-5dgnj11a	24	41	.	.	.
cord-346917-5dgnj11a	25	1	Appreciating	appreciate	VBG
cord-346917-5dgnj11a	25	2	the	the	DT
cord-346917-5dgnj11a	25	3	role	role	NN
cord-346917-5dgnj11a	25	4	of	of	IN
cord-346917-5dgnj11a	25	5	pro	pro	JJ
cord-346917-5dgnj11a	25	6	-	-	JJ
cord-346917-5dgnj11a	25	7	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	25	8	cytokines	cytokine	NNS
cord-346917-5dgnj11a	25	9	in	in	IN
cord-346917-5dgnj11a	25	10	the	the	DT
cord-346917-5dgnj11a	25	11	pathogenesis	pathogenesis	NN
cord-346917-5dgnj11a	25	12	of	of	IN
cord-346917-5dgnj11a	25	13	the	the	DT
cord-346917-5dgnj11a	25	14	disease	disease	NN
cord-346917-5dgnj11a	25	15	is	be	VBZ
cord-346917-5dgnj11a	25	16	important	important	JJ
cord-346917-5dgnj11a	25	17	as	as	IN
cord-346917-5dgnj11a	25	18	the	the	DT
cord-346917-5dgnj11a	25	19	scientific	scientific	JJ
cord-346917-5dgnj11a	25	20	community	community	NN
cord-346917-5dgnj11a	25	21	develops	develop	VBZ
cord-346917-5dgnj11a	25	22	therapeutics	therapeutic	NNS
cord-346917-5dgnj11a	25	23	to	to	TO
cord-346917-5dgnj11a	25	24	treat	treat	VB
cord-346917-5dgnj11a	25	25	patients	patient	NNS
cord-346917-5dgnj11a	25	26	.	.	.
cord-346917-5dgnj11a	26	1	IL-6	IL-6	NNP
cord-346917-5dgnj11a	26	2	inhibitors	inhibitor	NNS
cord-346917-5dgnj11a	26	3	such	such	JJ
cord-346917-5dgnj11a	26	4	as	as	IN
cord-346917-5dgnj11a	26	5	tocilizumab	tocilizumab	NNP
cord-346917-5dgnj11a	26	6	and	and	CC
cord-346917-5dgnj11a	26	7	siltuximab	siltuximab	NNS
cord-346917-5dgnj11a	26	8	are	be	VBP
cord-346917-5dgnj11a	26	9	already	already	RB
cord-346917-5dgnj11a	26	10	being	be	VBG
cord-346917-5dgnj11a	26	11	used	use	VBN
cord-346917-5dgnj11a	26	12	in	in	IN
cord-346917-5dgnj11a	26	13	the	the	DT
cord-346917-5dgnj11a	26	14	treatment	treatment	NN
cord-346917-5dgnj11a	26	15	of	of	IN
cord-346917-5dgnj11a	26	16	patients	patient	NNS
cord-346917-5dgnj11a	26	17	with	with	IN
cord-346917-5dgnj11a	26	18	severe	severe	JJ
cord-346917-5dgnj11a	26	19	COVID-19	covid-19	NN
cord-346917-5dgnj11a	26	20	in	in	IN
cord-346917-5dgnj11a	26	21	hopes	hope	NNS
cord-346917-5dgnj11a	26	22	of	of	IN
cord-346917-5dgnj11a	26	23	suppressing	suppress	VBG
cord-346917-5dgnj11a	26	24	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	26	25	responses	response	NNS
cord-346917-5dgnj11a	26	26	and	and	CC
cord-346917-5dgnj11a	26	27	have	have	VBP
cord-346917-5dgnj11a	26	28	been	be	VBN
cord-346917-5dgnj11a	26	29	adopted	adopt	VBN
cord-346917-5dgnj11a	26	30	in	in	IN
cord-346917-5dgnj11a	26	31	the	the	DT
cord-346917-5dgnj11a	26	32	most	most	RBS
cord-346917-5dgnj11a	26	33	recent	recent	JJ
cord-346917-5dgnj11a	26	34	Chinese	Chinese	NNP
cord-346917-5dgnj11a	26	35	National	National	NNP
cord-346917-5dgnj11a	26	36	Health	Health	NNP
cord-346917-5dgnj11a	26	37	Commission	Commission	NNP
cord-346917-5dgnj11a	26	38	Novel	Novel	NNP
cord-346917-5dgnj11a	26	39	Coronavirus	Coronavirus	NNP
cord-346917-5dgnj11a	26	40	Pneumonia	Pneumonia	NNP
cord-346917-5dgnj11a	26	41	guidelines	guideline	NNS
cord-346917-5dgnj11a	26	42	[	[	-LRB-
cord-346917-5dgnj11a	26	43	5	5	CD
cord-346917-5dgnj11a	26	44	,	,	,
cord-346917-5dgnj11a	26	45	7	7	CD
cord-346917-5dgnj11a	26	46	]	]	-RRB-
cord-346917-5dgnj11a	26	47	.	.	.
cord-346917-5dgnj11a	27	1	Additionally	additionally	RB
cord-346917-5dgnj11a	27	2	,	,	,
cord-346917-5dgnj11a	27	3	levels	level	NNS
cord-346917-5dgnj11a	27	4	of	of	IN
cord-346917-5dgnj11a	27	5	fibrinogen	fibrinogen	NN
cord-346917-5dgnj11a	27	6	,	,	,
cord-346917-5dgnj11a	27	7	D	d	NN
cord-346917-5dgnj11a	27	8	-	-	HYPH
cord-346917-5dgnj11a	27	9	dimer	dimer	NN
cord-346917-5dgnj11a	27	10	,	,	,
cord-346917-5dgnj11a	27	11	C	C	NNP
cord-346917-5dgnj11a	27	12	-	-	HYPH
cord-346917-5dgnj11a	27	13	reactive	reactive	JJ
cord-346917-5dgnj11a	27	14	protein	protein	NN
cord-346917-5dgnj11a	27	15	,	,	,
cord-346917-5dgnj11a	27	16	and	and	CC
cord-346917-5dgnj11a	27	17	ferritin	ferritin	NN
cord-346917-5dgnj11a	27	18	were	be	VBD
cord-346917-5dgnj11a	27	19	found	find	VBN
cord-346917-5dgnj11a	27	20	to	to	TO
cord-346917-5dgnj11a	27	21	be	be	VB
cord-346917-5dgnj11a	27	22	significantly	significantly	RB
cord-346917-5dgnj11a	27	23	higher	high	JJR
cord-346917-5dgnj11a	27	24	in	in	IN
cord-346917-5dgnj11a	27	25	patients	patient	NNS
cord-346917-5dgnj11a	27	26	with	with	IN
cord-346917-5dgnj11a	27	27	severe	severe	JJ
cord-346917-5dgnj11a	27	28	diseases	disease	NNS
cord-346917-5dgnj11a	27	29	compared	compare	VBN
cord-346917-5dgnj11a	27	30	to	to	IN
cord-346917-5dgnj11a	27	31	mild	mild	JJ
cord-346917-5dgnj11a	27	32	patients	patient	NNS
cord-346917-5dgnj11a	27	33	and	and	CC
cord-346917-5dgnj11a	27	34	are	be	VBP
cord-346917-5dgnj11a	27	35	other	other	JJ
cord-346917-5dgnj11a	27	36	potential	potential	JJ
cord-346917-5dgnj11a	27	37	laboratory	laboratory	NN
cord-346917-5dgnj11a	27	38	markers	marker	NNS
cord-346917-5dgnj11a	27	39	clinicians	clinician	NNS
cord-346917-5dgnj11a	27	40	can	can	MD
cord-346917-5dgnj11a	27	41	monitor	monitor	VB
cord-346917-5dgnj11a	27	42	over	over	IN
cord-346917-5dgnj11a	27	43	time	time	NN
cord-346917-5dgnj11a	27	44	to	to	TO
cord-346917-5dgnj11a	27	45	assess	assess	VB
cord-346917-5dgnj11a	27	46	how	how	WRB
cord-346917-5dgnj11a	27	47	individuals	individual	NNS
cord-346917-5dgnj11a	27	48	are	be	VBP
cord-346917-5dgnj11a	27	49	responding	respond	VBG
cord-346917-5dgnj11a	27	50	[	[	-LRB-
cord-346917-5dgnj11a	27	51	8	8	CD
cord-346917-5dgnj11a	27	52	]	]	-RRB-
cord-346917-5dgnj11a	27	53	.	.	.
cord-346917-5dgnj11a	28	1	This	this	DT
cord-346917-5dgnj11a	28	2	is	be	VBZ
cord-346917-5dgnj11a	28	3	consistent	consistent	JJ
cord-346917-5dgnj11a	28	4	with	with	IN
cord-346917-5dgnj11a	28	5	prior	prior	JJ
cord-346917-5dgnj11a	28	6	reports	report	NNS
cord-346917-5dgnj11a	28	7	that	that	IN
cord-346917-5dgnj11a	28	8	higher	high	JJR
cord-346917-5dgnj11a	28	9	levels	level	NNS
cord-346917-5dgnj11a	28	10	of	of	IN
cord-346917-5dgnj11a	28	11	C	c	NN
cord-346917-5dgnj11a	28	12	-	-	HYPH
cord-346917-5dgnj11a	28	13	reactive	reactive	JJ
cord-346917-5dgnj11a	28	14	protein	protein	NN
cord-346917-5dgnj11a	28	15	,	,	,
cord-346917-5dgnj11a	28	16	ferritin	ferritin	NN
cord-346917-5dgnj11a	28	17	and	and	CC
cord-346917-5dgnj11a	28	18	D	d	NN
cord-346917-5dgnj11a	28	19	-	-	HYPH
cord-346917-5dgnj11a	28	20	dimer	dimer	NN
cord-346917-5dgnj11a	28	21	were	be	VBD
cord-346917-5dgnj11a	28	22	associated	associate	VBN
cord-346917-5dgnj11a	28	23	with	with	IN
cord-346917-5dgnj11a	28	24	severe	severe	JJ
cord-346917-5dgnj11a	28	25	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	28	26	[	[	-LRB-
cord-346917-5dgnj11a	28	27	3	3	CD
cord-346917-5dgnj11a	28	28	]	]	-RRB-
cord-346917-5dgnj11a	28	29	.	.	.
cord-346917-5dgnj11a	29	1	This	this	DT
cord-346917-5dgnj11a	29	2	study	study	NN
cord-346917-5dgnj11a	29	3	was	be	VBD
cord-346917-5dgnj11a	29	4	limited	limit	VBN
cord-346917-5dgnj11a	29	5	to	to	IN
cord-346917-5dgnj11a	29	6	40	40	CD
cord-346917-5dgnj11a	29	7	COVID-19	covid-19	CD
cord-346917-5dgnj11a	29	8	patients	patient	NNS
cord-346917-5dgnj11a	29	9	,	,	,
cord-346917-5dgnj11a	29	10	thus	thus	RB
cord-346917-5dgnj11a	29	11	limiting	limit	VBG
cord-346917-5dgnj11a	29	12	the	the	DT
cord-346917-5dgnj11a	29	13	applicability	applicability	NN
cord-346917-5dgnj11a	29	14	to	to	IN
cord-346917-5dgnj11a	29	15	larger	large	JJR
cord-346917-5dgnj11a	29	16	populations	population	NNS
cord-346917-5dgnj11a	29	17	.	.	.
cord-346917-5dgnj11a	30	1	Furthermore	furthermore	RB
cord-346917-5dgnj11a	30	2	,	,	,
cord-346917-5dgnj11a	30	3	five	five	CD
cord-346917-5dgnj11a	30	4	of	of	IN
cord-346917-5dgnj11a	30	5	the	the	DT
cord-346917-5dgnj11a	30	6	severe	severe	JJ
cord-346917-5dgnj11a	30	7	patients	patient	NNS
cord-346917-5dgnj11a	30	8	had	have	VBD
cord-346917-5dgnj11a	30	9	fungal	fungal	JJ
cord-346917-5dgnj11a	30	10	or	or	CC
cord-346917-5dgnj11a	30	11	bacterial	bacterial	JJ
cord-346917-5dgnj11a	30	12	co	co	NNS
cord-346917-5dgnj11a	30	13	-	-	NNS
cord-346917-5dgnj11a	30	14	infections	infection	NNS
cord-346917-5dgnj11a	30	15	,	,	,
cord-346917-5dgnj11a	30	16	which	which	WDT
cord-346917-5dgnj11a	30	17	likely	likely	RB
cord-346917-5dgnj11a	30	18	confound	confound	VBP
cord-346917-5dgnj11a	30	19	associations	association	NNS
cord-346917-5dgnj11a	30	20	of	of	IN
cord-346917-5dgnj11a	30	21	inflammatory	inflammatory	JJ
cord-346917-5dgnj11a	30	22	dysfunction	dysfunction	NN
cord-346917-5dgnj11a	30	23	with	with	IN
cord-346917-5dgnj11a	30	24	specific	specific	JJ
cord-346917-5dgnj11a	30	25	features	feature	NNS
cord-346917-5dgnj11a	30	26	of	of	IN
cord-346917-5dgnj11a	30	27	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	30	28	disease	disease	NN
cord-346917-5dgnj11a	30	29	.	.	.
cord-346917-5dgnj11a	31	1	Although	although	IN
cord-346917-5dgnj11a	31	2	N8R	n8r	CD
cord-346917-5dgnj11a	31	3	and	and	CC
cord-346917-5dgnj11a	31	4	NLR	NLR	NNP
cord-346917-5dgnj11a	31	5	remained	remain	VBD
cord-346917-5dgnj11a	31	6	significant	significant	JJ
cord-346917-5dgnj11a	31	7	predictors	predictor	NNS
cord-346917-5dgnj11a	31	8	of	of	IN
cord-346917-5dgnj11a	31	9	COVID-19	covid-19	JJ
cord-346917-5dgnj11a	31	10	outcome	outcome	NN
cord-346917-5dgnj11a	31	11	when	when	WRB
cord-346917-5dgnj11a	31	12	the	the	DT
cord-346917-5dgnj11a	31	13	patients	patient	NNS
cord-346917-5dgnj11a	31	14	with	with	IN
cord-346917-5dgnj11a	31	15	fungal	fungal	JJ
cord-346917-5dgnj11a	31	16	infections	infection	NNS
cord-346917-5dgnj11a	31	17	were	be	VBD
cord-346917-5dgnj11a	31	18	removed	remove	VBN
cord-346917-5dgnj11a	31	19	,	,	,
cord-346917-5dgnj11a	31	20	larger	large	JJR
cord-346917-5dgnj11a	31	21	studies	study	NNS
cord-346917-5dgnj11a	31	22	that	that	WDT
cord-346917-5dgnj11a	31	23	can	can	MD
cord-346917-5dgnj11a	31	24	account	account	VB
cord-346917-5dgnj11a	31	25	for	for	IN
cord-346917-5dgnj11a	31	26	variables	variable	NNS
cord-346917-5dgnj11a	31	27	introduced	introduce	VBN
cord-346917-5dgnj11a	31	28	by	by	IN
cord-346917-5dgnj11a	31	29	co	co	NNS
cord-346917-5dgnj11a	31	30	-	-	NNS
cord-346917-5dgnj11a	31	31	infections	infection	NNS
cord-346917-5dgnj11a	31	32	are	be	VBP
cord-346917-5dgnj11a	31	33	needed	need	VBN
cord-346917-5dgnj11a	31	34	.	.	.
cord-346917-5dgnj11a	32	1	A	a	DT
cord-346917-5dgnj11a	32	2	subset	subset	NN
cord-346917-5dgnj11a	32	3	of	of	IN
cord-346917-5dgnj11a	32	4	patients	patient	NNS
cord-346917-5dgnj11a	32	5	received	receive	VBD
cord-346917-5dgnj11a	32	6	methylprednisolone	methylprednisolone	NN
cord-346917-5dgnj11a	32	7	,	,	,
cord-346917-5dgnj11a	32	8	a	a	DT
cord-346917-5dgnj11a	32	9	corticosteroid	corticosteroid	NN
cord-346917-5dgnj11a	32	10	with	with	IN
cord-346917-5dgnj11a	32	11	known	know	VBN
cord-346917-5dgnj11a	32	12	DOI	doi	NN
cord-346917-5dgnj11a	32	13	of	of	IN
cord-346917-5dgnj11a	32	14	original	original	JJ
cord-346917-5dgnj11a	32	15	article	article	NN
cord-346917-5dgnj11a	32	16	:	:	:
cord-346917-5dgnj11a	32	17	http://dx.doi.org/10.1016/j.ebiom.2020.102763	http://dx.doi.org/10.1016/j.ebiom.2020.102763	NNP
cord-346917-5dgnj11a	32	18	.	.	.
cord-346917-5dgnj11a	33	1	Longitudinal	longitudinal	JJ
cord-346917-5dgnj11a	33	2	characteristics	characteristic	NNS
cord-346917-5dgnj11a	33	3	of	of	IN
cord-346917-5dgnj11a	33	4	lymphocyte	lymphocyte	NN
cord-346917-5dgnj11a	33	5	responses	response	NNS
cord-346917-5dgnj11a	33	6	and	and	CC
cord-346917-5dgnj11a	33	7	cytokine	cytokine	NN
cord-346917-5dgnj11a	33	8	profiles	profile	NNS
cord-346917-5dgnj11a	33	9	in	in	IN
cord-346917-5dgnj11a	33	10	the	the	DT
cord-346917-5dgnj11a	33	11	peripheral	peripheral	JJ
cord-346917-5dgnj11a	33	12	blood	blood	NN
cord-346917-5dgnj11a	33	13	of	of	IN
cord-346917-5dgnj11a	33	14	SARS	SARS	NNP
cord-346917-5dgnj11a	33	15	-	-	HYPH
cord-346917-5dgnj11a	33	16	CoV-2	CoV-2	NNP
cord-346917-5dgnj11a	33	17	infected	infect	VBN
cord-346917-5dgnj11a	33	18	patients	patient	NNS
cord-346917-5dgnj11a	33	19	Pathogenic	pathogenic	JJ
cord-346917-5dgnj11a	33	20	human	human	JJ
cord-346917-5dgnj11a	33	21	coronavirus	coronavirus	NN
cord-346917-5dgnj11a	33	22	infections	infection	NNS
cord-346917-5dgnj11a	33	23	:	:	:
cord-346917-5dgnj11a	33	24	causes	cause	NNS
cord-346917-5dgnj11a	33	25	and	and	CC
cord-346917-5dgnj11a	33	26	consequences	consequence	NNS
cord-346917-5dgnj11a	33	27	of	of	IN
cord-346917-5dgnj11a	33	28	cytokine	cytokine	NN
cord-346917-5dgnj11a	33	29	storm	storm	NN
cord-346917-5dgnj11a	33	30	and	and	CC
cord-346917-5dgnj11a	33	31	immunopathology	immunopathology	NN
cord-346917-5dgnj11a	33	32	Clinical	clinical	JJ
cord-346917-5dgnj11a	33	33	and	and	CC
cord-346917-5dgnj11a	33	34	immunologic	immunologic	JJ
cord-346917-5dgnj11a	33	35	features	feature	NNS
cord-346917-5dgnj11a	33	36	in	in	IN
cord-346917-5dgnj11a	33	37	severe	severe	JJ
cord-346917-5dgnj11a	33	38	and	and	CC
cord-346917-5dgnj11a	33	39	moderate	moderate	JJ
cord-346917-5dgnj11a	33	40	coronavirus	coronavirus	NN
cord-346917-5dgnj11a	33	41	disease	disease	NN
cord-346917-5dgnj11a	34	1	2019	2019	CD
cord-346917-5dgnj11a	34	2	Clinical	clinical	JJ
cord-346917-5dgnj11a	34	3	and	and	CC
cord-346917-5dgnj11a	34	4	biochemical	biochemical	JJ
cord-346917-5dgnj11a	34	5	indexes	index	NNS
cord-346917-5dgnj11a	34	6	from	from	IN
cord-346917-5dgnj11a	34	7	2019-nCoV	2019-ncov	CD
cord-346917-5dgnj11a	34	8	infected	infect	VBN
cord-346917-5dgnj11a	34	9	patients	patient	NNS
cord-346917-5dgnj11a	34	10	linked	link	VBN
cord-346917-5dgnj11a	34	11	to	to	IN
cord-346917-5dgnj11a	34	12	viral	viral	JJ
cord-346917-5dgnj11a	34	13	loads	load	NNS
cord-346917-5dgnj11a	34	14	and	and	CC
cord-346917-5dgnj11a	34	15	lung	lung	NN
cord-346917-5dgnj11a	34	16	injury	injury	NN
cord-346917-5dgnj11a	34	17	Interleukin-6	Interleukin-6	NNP
cord-346917-5dgnj11a	34	18	in	in	IN
cord-346917-5dgnj11a	34	19	COVID-19	COVID-19	NNP
cord-346917-5dgnj11a	34	20	:	:	:
cord-346917-5dgnj11a	34	21	a	a	DT
cord-346917-5dgnj11a	34	22	Systematic	Systematic	NNP
cord-346917-5dgnj11a	34	23	Review	Review	NNP
cord-346917-5dgnj11a	34	24	and	and	CC
cord-346917-5dgnj11a	34	25	Meta	Meta	NNP
cord-346917-5dgnj11a	34	26	-	-	HYPH
cord-346917-5dgnj11a	34	27	Analysis	Analysis	NNP
cord-346917-5dgnj11a	34	28	Potential	potential	JJ
cord-346917-5dgnj11a	34	29	factors	factor	NNS
cord-346917-5dgnj11a	34	30	for	for	IN
cord-346917-5dgnj11a	34	31	prediction	prediction	NN
cord-346917-5dgnj11a	34	32	of	of	IN
cord-346917-5dgnj11a	34	33	disease	disease	NN
cord-346917-5dgnj11a	34	34	severity	severity	NN
cord-346917-5dgnj11a	34	35	of	of	IN
cord-346917-5dgnj11a	34	36	COVID-19	covid-19	CD
cord-346917-5dgnj11a	34	37	patients	patient	NNS
cord-346917-5dgnj11a	34	38	China	China	NNP
cord-346917-5dgnj11a	34	39	National	National	NNP
cord-346917-5dgnj11a	34	40	Health	Health	NNP
cord-346917-5dgnj11a	34	41	Commission	Commission	NNP
cord-346917-5dgnj11a	34	42	.	.	.
cord-346917-5dgnj11a	35	1	《	《	NNP
cord-346917-5dgnj11a	35	2	新型冠状病毒肺炎诊疗方案	新型冠状病毒肺炎诊疗方案	NNP
cord-346917-5dgnj11a	35	3	(	(	-LRB-
cord-346917-5dgnj11a	35	4	试行第七版	试行第七版	NN
cord-346917-5dgnj11a	35	5	)	)	-RRB-
cord-346917-5dgnj11a	35	6	》	》	NNP
cord-346917-5dgnj11a	36	1	解读	解读	NNP
cord-346917-5dgnj11a	36	2	n.d	n.d	NNP
cord-346917-5dgnj11a	36	3	.	.	.
cord-346917-5dgnj11a	37	1	2020	2020	CD
cord-346917-5dgnj11a	38	1	The	the	DT
cord-346917-5dgnj11a	38	2	potential	potential	JJ
cord-346917-5dgnj11a	38	3	role	role	NN
cord-346917-5dgnj11a	38	4	of	of	IN
cord-346917-5dgnj11a	38	5	IL-6	IL-6	NNP
cord-346917-5dgnj11a	38	6	in	in	IN
cord-346917-5dgnj11a	38	7	monitoring	monitor	VBG
cord-346917-5dgnj11a	38	8	severe	severe	JJ
cord-346917-5dgnj11a	38	9	case	case	NN
cord-346917-5dgnj11a	38	10	of	of	IN
cord-346917-5dgnj11a	38	11	coronavirus	coronavirus	NN
cord-346917-5dgnj11a	38	12	disease	disease	NN
cord-346917-5dgnj11a	38	13	2019	2019	CD
cord-346917-5dgnj11a	39	1	The	the	DT
cord-346917-5dgnj11a	39	2	authors	author	NNS
cord-346917-5dgnj11a	39	3	declare	declare	VBP
cord-346917-5dgnj11a	39	4	no	no	DT
cord-346917-5dgnj11a	39	5	conflict	conflict	NN
cord-346917-5dgnj11a	39	6	of	of	IN
cord-346917-5dgnj11a	39	7	interest	interest	NN
cord-346917-5dgnj11a	39	8	.	.	.